尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Gault Laura. Insider active across 1 company, notably Sage Therapeutics, Inc.. Cumulatively, 4 disclosures have been recorded. History available since 13 February 2024. The latest transaction was filed on 13 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant linked to Sage Therapeutics, Inc. (XNAS), where she is Chief Medical Officer. The file records 4 filings in total, and the sampled recent filings cover the period from 2024-02-15 to 2025-02-14, with the transaction nature shown as Attribution.